Castellan Group Buys 44 Shares of McKesson Co. (NYSE:MCK)

Castellan Group raised its stake in McKesson Co. (NYSE:MCK) by 0.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,244 shares of the company’s stock after acquiring an additional 44 shares during the period. McKesson makes up 2.5% of Castellan Group’s portfolio, making the stock its 16th largest holding. Castellan Group’s holdings in McKesson were worth $5,838,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of MCK. Hemington Wealth Management increased its holdings in shares of McKesson by 18.6% in the 4th quarter. Hemington Wealth Management now owns 115 shares of the company’s stock worth $65,000 after buying an additional 18 shares during the last quarter. Ingalls & Snyder LLC increased its holdings in shares of McKesson by 8.2% in the 4th quarter. Ingalls & Snyder LLC now owns 13,824 shares of the company’s stock worth $7,878,000 after buying an additional 1,047 shares during the last quarter. Consolidated Planning Corp increased its holdings in shares of McKesson by 106.6% in the 4th quarter. Consolidated Planning Corp now owns 2,363 shares of the company’s stock worth $1,347,000 after buying an additional 1,219 shares during the last quarter. Avion Wealth increased its holdings in shares of McKesson by 47.1% in the 4th quarter. Avion Wealth now owns 306 shares of the company’s stock worth $174,000 after buying an additional 98 shares during the last quarter. Finally, Lester Murray Antman dba SimplyRich increased its holdings in shares of McKesson by 1.0% in the 4th quarter. Lester Murray Antman dba SimplyRich now owns 5,191 shares of the company’s stock worth $2,958,000 after buying an additional 53 shares during the last quarter. 85.07% of the stock is currently owned by institutional investors.

McKesson Stock Performance

Shares of MCK opened at $595.24 on Thursday. The company has a 50 day moving average price of $587.89 and a 200-day moving average price of $562.68. McKesson Co. has a fifty-two week low of $464.42 and a fifty-two week high of $637.51. The stock has a market capitalization of $75.56 billion, a PE ratio of 27.25, a PEG ratio of 1.30 and a beta of 0.52.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Equities research analysts forecast that McKesson Co. will post 32.69 EPS for the current year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be given a $0.71 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.48%. McKesson’s payout ratio is presently 13.00%.

Analyst Upgrades and Downgrades

MCK has been the topic of a number of research reports. Baird R W upgraded shares of McKesson from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 7th. Morgan Stanley lifted their price target on shares of McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Robert W. Baird raised shares of McKesson from a “neutral” rating to an “outperform” rating and lifted their price target for the stock from $531.00 to $688.00 in a research note on Thursday, November 7th. Evercore ISI lifted their price target on shares of McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a research note on Thursday, February 6th. Finally, Bank of America dropped their price target on shares of McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Two research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, McKesson has a consensus rating of “Buy” and a consensus price target of $645.79.

Insider Transactions at McKesson

In related news, EVP Leann B. Smith sold 579 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the completion of the transaction, the executive vice president now owns 864 shares in the company, valued at $494,890.56. The trade was a 40.12 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.11% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.